Advantage Investment Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
Other funds holding GWPH
PP
Advantage Investment Management's GWPH Position: Q3 2019 in Review
Advantage Investment Management increased its GW Pharmaceuticals Plc American Depositary Shares (GWPH) stake by 5.1% in Q3 2019, buying an estimated $3.79K and bringing the position to 512 shares worth $59K. The position accounts for 0.05% of the portfolio, ranked #309.
Advantage Investment Management first reported a position in GWPH in Q4 2014 and has held it in 20 quarters since. The position peaked at $97K in Q3 2018. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.
- Advantage Investment Management held 512 shares of GW Pharmaceuticals Plc American Depositary Shares worth $59K as of Q3 2019.
- Advantage Investment Management bought 25 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2019, an estimated $3.79K.
- GW Pharmaceuticals Plc American Depositary Shares made up 0.05% of Advantage Investment Management's portfolio in Q3 2019, its #309 holding.
- Advantage Investment Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2014 and has held it in 20 quarters since.
- Advantage Investment Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $97K in Q3 2018.
- 316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.
Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.